Astragalus.
May support immune health and energy levels. Traditionally used to support the immune system and boost energy. Think of it as a background tune-up to help your body handle stress.
Reviewed March 2026
- Category
- Herb
- Also filed under
- Immune SupportEnergyAdaptogen
What Astragalus is, and what it does.
- Does it work
- Maybe. It has a long history, but the human data is still a bit thin. If you're generally healthy and curious, it's a low-risk experiment.
- How much to take
- Start with 250-500mg of a standardized extract daily. Some studies use more, but this is a good starting point.
- Time to feel it
- Four to six weeks of daily use is the usual window. The changes trials pick up are in immune and antioxidant markers rather than in how a day feels.
- The first dose
- Absolutely nothing. This isn't a pre-workout. It needs time to build up in your system.
- With regular use
- After 4-6 weeks, you might feel a bit more resilient. Fewer sniffles, better baseline energy. The effect is subtle.
- How well tolerated
- Generally well tolerated for healthy people. The main caution is for those with autoimmune conditions, as it can ramp up the immune system.
- How it feels
- Quiet. No buzz, no rush. It's more about what you don't feel: getting sick as often or feeling constantly drained.
- The overlooked benefit
- Its large sugar molecules are not digested by human enzymes, so they arrive in the colon intact and become food for your gut bacteria.
250 to 500mg a day is where Astragalus works.
Source: Liu et al. 2017 Am J Chin Med review; Chinese Pharmacopoeia monograph.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
While traditional use is extensive, modern scientific evidence is still emerging and sometimes inconsistent. Some studies show positive effects, while others are less conclusive. More research is needed to fully understand its potential.
- Immune cell signallingIn vitro study
- Everyday fatigue and quality of lifeRandomised trial
- Antioxidant markersRandomised trial
- Gut microbiota fermentation of astragalus polysaccharideAnimal study
- Traditional use as an energy and immune tonicNarrative review
Questions people ask about Astragalus.
- Is this like an energy drink?
- No. It's a slow-burn adaptogen, not a stimulant. No jitters, no crash.
- What's an 'adaptogen'?
- Something that helps your body adapt to stress. Not a magic bullet, more like a gentle buffer.
- Does it work right away?
- Nope. Give it at least a month of daily use. Patience is required.
- What does 'standardized' mean on the label?
- It means the amount of the active ingredient (astragalosides) is guaranteed. Look for that.
- Is it better as a tea or capsule?
- Capsules. Teas have inconsistent dosing. Go for the standardized extract in a pill for reliability.
- Can I take it every day?
- Yes, it's meant for consistent, long-term use. Some people cycle it, but daily is common.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Astragalus and dong quai are the two components of a long-standing paired formula given in a roughly five to one ratio, where the astragalus fraction supports normal blood-building processes that the dong quai fraction complements. The pairing is one of the most documented herb combinations in traditional practice and reflects settled formulation logic rather than a single study.
Both are traditional qi-supporting tonics that appear together in classical energy formulas, with astragalus polysaccharides and ginseng ginsenosides supporting normal immune and stress-response function through complementary rather than identical mechanisms. Combining them is long-standing formulation practice for general vitality support.
Astragalus polysaccharides and reishi beta-glucans both engage innate immune receptors that recognize complex sugars, so pairing them layers two distinct polysaccharide inputs that support normal immune-cell activity. Stacking these two is common formulation practice in immune-support blends.
Astragalus and licorice are the paired qi tonics of classical Chinese formulas, licorice acting as the harmonising component of the same decoction. Both carry saponin and polysaccharide fractions with distinct targets.
Eleutherosides act on the stress axis while astragalus polysaccharides act on innate immune recognition, two separate routes routinely combined in one tonic.
Rosavins and salidroside act on monoamine handling and stress signalling, a different arm from the polysaccharide immune route astragalus works through. Long practice places them in the same daily tonic.
Withanolides act on cortisol dynamics while astragalus works on immune polysaccharide recognition, so the two split the stress and immune halves of a tonic formula. They come from unrelated chemistries.
Cordyceps beta-glucans and cordycepin engage pattern recognition receptors and cellular energy handling, alongside astragalus polysaccharides at the same receptor family. The pairing is long-standing in Chinese tonic practice.
Schisandra lignans support hepatic phase I and phase II handling, the same clearance route a long astragalus course loads. Both appear together in traditional adaptogen decoctions.
Turkey tail's protein-bound polysaccharides signal through dectin-1 and TLR2, receptors astragalus polysaccharides also engage. Combining fungal and plant polysaccharides broadens the recognition profile.
Maitake beta-1,6 branched glucans act on the same innate receptors astragalan does, from a different branching pattern. Formulators stack them for breadth of glucan structure rather than dose.
Chaga brings betulinic acid derived triterpenes and melanin complexes on top of its glucans, chemistries astragalus does not supply. Both are prepared as long-simmered decoctions in the same traditions.
American ginseng carries a ginsenoside profile weighted toward Rb1, a cooler tonic than Asian ginseng and the traditional partner for astragalus in the same formula. Saponin and polysaccharide fractions act on different targets.
Ascorbate is a required cofactor in normal neutrophil and lymphocyte function, which no botanical polysaccharide can replace. It is the standard nutrient base an astragalus extract is layered on.
Zinc is structurally required in the transcription factors that drive normal immune cell maturation. Supplying it addresses a requirement astragalus polysaccharides act downstream of.
Astragalus polysaccharide is not digested by mammalian enzymes and reaches the colon, where fermentation studies in animals report shifts toward butyrate-producing bacteria. Supplemental butyrate delivers the end product directly; the polysaccharide supplies substrate for its production. The evidence for this link is animal and in vitro, not human.
Both astragalus polysaccharide and inulin escape small-intestinal digestion and are fermented in the colon, so they add to the same fermentable load. The bacterial guilds they favour overlap only partly, since the sugar backbones differ. Combining them raises total substrate, with the tolerance consequences that implies.
In vitro fermentation of astragalus polysaccharide with human or animal faecal inocula shifts the microbial community, which is the substrate side of a synbiotic pairing. Whether a given probiotic strain can use the polysaccharide depends on its glycoside hydrolase repertoire. The pairing is a design rationale supported by laboratory fermentation, not by a human combination trial.
Bifidobacteria carry broad carbohydrate-active enzyme sets and are among the genera reported to expand during fermentation of plant polysaccharides. Astragalus polysaccharide provides such a substrate. Strain-level capacity varies, so this is a rationale rather than a fixed outcome.
Lactobacillus plantarum is metabolically versatile and is a common partner strain in fermented herbal preparations, including fermented astragalus. Fermentation before ingestion also hydrolyses isoflavonoid glycosides to their aglycones, changing what is absorbed. The evidence sits in process chemistry and animal feeding work.
Yeast beta-glucan engages dectin-1 and complement receptor 3 on innate immune cells, and astragalus polysaccharide is described as engaging pattern recognition receptors including TLR4 in laboratory models. The two act on the innate side of normal immune signalling by related but distinct routes. Whether combining them adds anything in people has not been tested here.
Selenium is required for glutathione peroxidases and thioredoxin reductases, the enzymes that handle peroxides, while astragalus extracts show antioxidant activity in laboratory and animal models. The two support the same general function through different means, one as an enzyme cofactor and one as a plant extract. They are frequently combined in immune-support formulas on that reasoning.
Calcitriol acts through the vitamin D receptor on immune cells to support normal immune cell function, a route entirely separate from astragalus polysaccharide signalling. Formulators pair them for that non-overlap. No combination study is described here.
Elderberry contributes anthocyanins and astragalus contributes polysaccharides and saponins, and the two appear together in seasonal immune-support blends. The rationale is compositional breadth rather than a shared mechanism. Nothing here tests the pair.
Catechins from green tea and the flavonoids and saponins in astragalus both register as antioxidants in laboratory assays. Assay activity is a marker, not an outcome in a person. The combination has not been evaluated in the sources at hand.
Both plants are described as modulating Nrf2-linked antioxidant signalling in cell and animal models. Curcumin's poor oral bioavailability is a separate constraint that astragalus does not address. The pairing is mechanistic and untested together in people.
Astragalus root carries isoflavonoids such as calycosin and formononetin, both of which arrive as glycosides that gut bacteria deglycosylate before absorption, and quercetin follows the same glycoside-to-aglycone pattern. Supplying isolated quercetin adds far more of a single flavonoid than the root contributes. The link is chemical family, not a demonstrated combination.
Talk to a doctor before taking Astragalus if any of these apply to you: Autoimmune conditions, Pregnancy, Breastfeeding, Medications affecting the immune system. These are flags to check first, not effects Astragalus is known to cause.
Not medical advice. Show the label to your pharmacist.What Astragalus actually does.
Astragalus root brings two main families of compounds: cycloartane-type triterpene saponins, astragaloside IV among them, and large polysaccharides usually listed as astragalus polysaccharide.
Your digestive enzymes don't break astragalus polysaccharide down, so it reaches your colon intact and is available there for your resident gut bacteria to ferment.
The root's isoflavonoids, mainly calycosin and formononetin, turn up mostly with sugars attached, and gut bacterial enzymes have to cut those sugars off before much of anything gets absorbed.
Species and plant part change the compound profile. Astragalus membranaceus and Astragalus mongholicus are both used, and root material differs a lot from the stems and leaves used in some feed studies.
Where Astragalus comes from.
Astragalus starts as a root grown for several years, then washed, sliced and dried. Grind it and you get plain root powder. Simmer it in water and concentrate the liquid and you get an extract rich in the large sugar molecules. Use alcohol and water instead and you get one rich in the saponins measured as astragaloside IV. Ferment it first and the plant compounds are partly converted before you swallow them. Same plant, four quite different powders, so the label needs to say which.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Roots are grown for several years, commonly four or more, mostly in northern China and Mongolia, and lifted in autumn after the aerial parts die back
Roots are washed, the rootlets and crown removed, then sliced lengthwise or transversely into the characteristic pale yellow slices
Slices are sun-dried or dried in a controlled dryer to a moisture level that halts microbial growth; honey-frying is a separate traditional processing step applied to some material
Hot water is used when the polysaccharide fraction is the target; an ethanol-water mixture is used when the saponins and isoflavonoids are, and the choice determines the extract's character
The liquor is filtered and concentrated under vacuum; polysaccharide processes often add alcohol precipitation, saponin processes often pass the concentrate over macroporous resin
Astragaloside IV is quantified by HPLC and polysaccharide content by a colorimetric carbohydrate assay, with a carrier such as maltodextrin used to hit the declared figure
The concentrate is spray-dried to a free-flowing powder, then blended, encapsulated or tabletted; cut root and whole-root powder skip the extraction chain entirely
The forms it comes in.
The essence, in one line each.
- In adults with high blood sugar and reduced kidney function, adding astragalus for 48 weeks slowed the yearly decline in kidney filtration rate by about 4.6 mL/min/1.73m2 and lowered systolic blood pressure by about 7.9 mmHg versus standard care alone.Randomised trial. Chan et al., 2024 (Phytomedicine). PMID 38810556 ↗
- Across 32 randomised trials in 2,462 adults with high blood sugar and reduced kidney function, astragalus was associated with lower urinary protein excretion and lower serum creatinine, markers of kidney workload.Systematic review. Lin et al., 2024 (Renal Failure). PMID 38836372 ↗
- In 40 healthy adults averaging 56 years, six months of a multi-ingredient astragalus-based supplement was followed by longer median telomere length (p = 0.01) and a lower share of short telomeres, a cellular marker, while the placebo group showed no change.Randomised trial. de Jaeger et al., 2024 (Nutrients). PMID 39275278 ↗
- In 24 moderately active adults, astragalus root taken through 10 weeks of resistance training added no detectable strength gain over placebo, while TNF-alpha and IL-6 did not rise during the intensified training block as they did on placebo.Randomised trial. Villanova et al., 2026 (Nutrients). PMID 42197058 ↗
- In healthy adults reporting knee discomfort, 12 weeks of astragalus saponins showed within-group gains in single-leg step-down count and knee range of motion, but no significant difference against placebo, so the effect is unconfirmed.Randomised trial. Zhuang et al., 2026 (Nutrients). PMID 42356230 ↗
- Pooling controlled trials of astragalus polysaccharides given alongside conventional hospital care, the authors report differences in reported quality-of-life and tolerability measures versus control; the trials were mostly small and conducted in one region.Meta-analysis. Li et al., 2025 (Naunyn-Schmiedeberg's Archives of Pharmacology). PMID 40208321 ↗
- A review of herbal and traditional-medicine interventions for age-related loss of muscle mass and strength that names astragalus among the intervention components; the finding belongs to the pooled category, not to astragalus alone.Systematic review. Chiang et al., 2026 (Complementary Medicine Research). PMID 42096355 ↗
- In vitro fermentation of astragalus polysaccharide altered the composition of the microbial community and its metabolite output; this is a laboratory fermentation model, not an effect measured in a person.In vitro study. Lin et al., 2026 (Frontiers in Psychiatry). PMID 41822218 ↗
- Pooling broiler feeding studies, the authors report that astragalus polysaccharides were associated with changes in antioxidant markers and gut measures alongside performance gains.Meta-analysis. Feng et al., 2026 (Journal of Animal Physiology and Animal Nutrition). PMID 41328582 ↗
- Astragalus polysaccharides shifted the gut community toward butyrate-producing bacteria and altered metabolic measures in sows across the perinatal period.Animal study. Dai et al., 2026 (Microbiology Spectrum). PMID 42294883 ↗
- Astragalus stems and leaves in the diet were associated with changes in antioxidant and immune status markers and in gut microbiota in broilers; the plant part used was aerial material, not root.Animal study. Guo et al., 2026 (Poultry Science). PMID 42241764 ↗
- Dietary astragalus polysaccharide altered growth performance, carcass traits and meat quality measures in the birds studied.Animal study. Zhang et al., 2026 (Poultry Science). PMID 42173012 ↗
- In common carp, astragalus polysaccharides were associated with higher antioxidant capacity measures and changes in muscle composition and metabolic markers.Animal study. Zhang et al., 2026 (International Journal of Biological Macromolecules). PMID 42297173 ↗
- Supplementing astragalus and fermented astragalus changed rumen microbiota and lactation performance measures differently, indicating that fermentation of the raw material alters what the animal receives.Animal study. Lu et al., 2026 (Frontiers in Microbiology). PMID 42254496 ↗
- Astragalus polysaccharides reshaped the gut resistome of postpartum dairy cows, a microbial-gene-level observation rather than a health outcome.Animal study. Luo et al., 2026 (Bioresource Technology). PMID 42442424 ↗
- A combined Astragalus membranaceus and Panax notoginseng saponins extract was tested against control, so any effect belongs to the mixture rather than to either plant alone.Randomised trial. Zhuang et al., 2026 (Nutrients). PMID 41683325 ↗
These are the studies our verdict leans on, chosen from the 882 we read for Astragalus. The full linked list is below.
The studies, linked.
1 source behind our Astragalus verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialEfficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease (READY) - An Open-label Randomised Controlled Trial With Responder Regression AnalysisClinicalTrials.gov ↗PHASE2 · 118 participants · Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 1,206 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Astragalus is, not how risky it is. A report is not proof Astragalus caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.




